Company Name: |
DC Chemicals
|
Tel: |
021-58447131 13564518121 |
Email: |
sales@dcchemicals.com |
Products Intro: |
Product Name:IM-250 CAS:2305750-23-4 Purity:98% HPLC Package:100mg,250mg,1g
|
Company Name: |
TargetMol Chemicals Inc.
|
Tel: |
4008200310 |
Email: |
marketing@tsbiochem.com |
Products Intro: |
Product Name:IM-250 CAS:2305750-23-4 Purity:99.59% Package:1mg/RMB 1560;5mg/RMB 5230;10mg/RMB 7190
|
Company Name: |
Nantong QuanYi Biotechnology Co., Ltd
|
Tel: |
0513-66337626 18051384581 |
Email: |
sales@chemhifuture.com |
Products Intro: |
Product Name:IM-250 CAS:2305750-23-4 Purity:98%+ HPLC Package:10mg,500mg,1g,2g,5g,10mg,more
|
Company Name: |
Shanghai Yifei Biotechnology Co. , Ltd.
|
Tel: |
021-65675885 18964387627 |
Email: |
customer_service@efebio.com |
Products Intro: |
Product Name:IM-250 CAS:2305750-23-4 Purity:99% Package:1mg;5mg;10mg
|
|
| INDEX NAME NOT YET ASSIGNED Basic information |
| INDEX NAME NOT YET ASSIGNED Chemical Properties |
Boiling point | 573.0±60.0 °C(Predicted) | density | 1.36±0.1 g/cm3(Predicted) | form | Solid | color | White to off-white |
| INDEX NAME NOT YET ASSIGNED Usage And Synthesis |
Uses | IM-250 is an orally active helicase-primase inhibitor. IM-250 is effective against HSV infection. IM-250 inhibits HSV-1 infection in Vero cells (IC50: ~20 nM)[1][2]. | References | [1] Bernstein DI, et al. Intermittent therapy with helicase-primase inhibitor IM-250 efficiently controls recurrent herpes disease and reduces reactivation of latent HSV. Antiviral Res. 2023 Nov;219:105733. DOI:10.1016/j.antiviral.2023.105733 [2] Uhlig N, et al. Helicase primase inhibitors (HPIs) are efficacious for therapy of human herpes simplex virus (HSV) disease in an infection mouse model. Antiviral Res. 2021 Nov;195:105190. DOI:10.1016/j.antiviral.2021.105190 |
| INDEX NAME NOT YET ASSIGNED Preparation Products And Raw materials |
|